The Third Circuit on Wednesday revived a securities fraud class action against pharmaceutical company Ocugen Inc., scrapping a decades-old circuit rule that treated a stock price's failure to move after a corr... (more story)

Novo Nordisk has agreed to pay up to about €1.165 billion ($1.3 billion) under an exclusive license and collaboration agreement for Swedish drug-delivery company Nanexa's PharmaShell technology.

In this week's Taxation With Representation, Royal Caribbean invests billions in a joint venture with Sandals, Telix Pharmaceuticals buys ITM Isotope Technologies Munich, and Priority Technology makes a go-pri... (more story)

A New York federal judge gave Novartis permanent relief from a proposed class action alleging it monopolistically delayed generic competition for its blockbuster heart failure drug Entresto, concluding that th... (more story)

A California state appeals court held in a published opinion that health insurer reimbursements for services are prices that, if fixed or tampered with, are subject to antitrust scrutiny, reviving a lawsuit th... (more story)

Private equity-backed radiopharmaceutical company Curium reset the clock for the Federal Trade Commission's 30-day review of its plan to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an ... (more story)

Social media companies and teens who allege the companies harmed their mental health sparred in California state court Tuesday over what evidence jurors will hear in an upcoming round of bellwether trials, inc... (more story)

Intuitive Surgical asked the full Ninth Circuit to reconsider a decision reviving a surgical repair company's claims that it blocked third parties from refurbishing components for its popular da Vinci surgery ... (more story)

Big players in the news business are weighing in on an obscure legal clash over a hospital rating system they say could have massive implications for free speech and the American press.

Amid lawmaker pressure, the FDA made clear that animal testing isn't required in drug development. Life sciences experts say a new rule doesn't relax evidentiary standards for drug safety and testing.

A Delaware bankruptcy judge granted his approval Monday to the bidding procedures proposed in the Chapter 11 case of a company that uses artificial intelligence to explore new uses for existing drugs.

An Astrana Health unit was the target of a "series" of social engineering cyberattacks in which hackers impersonated the company's employees to gain access to systems that contained private and confidential in... (more story)

A Massachusetts federal judge granted Aetna's bid Wednesday to dismiss claims against it in consolidated antitrust litigation accusing insurance companies of using Zelis Healthcare's repricing tools to reduce ... (more story)

More than 100 former NFL players spoke against a proposed class action settlement over allegedly discriminatory cognitive disability assessments, telling a federal judge it threatens to release the league's be... (more story)

A North Carolina pharmaceutical company says in a complaint filed Wednesday in Massachusetts state court that the company it hired to package a drug for clinical trials involving young children intentionally d... (more story)

A whistleblower must turn to state courts to pursue his bid for a portion of a $4.7 billion settlement between Walgreens Boots Alliance Inc. and a group of states resolving opioid-related claims against the re... (more story)

Federal health officials didn't violate federal law when they implemented a competitive rule that will alter how organ procurers are rated by decertifying low performers, a Florida federal judge ruled, a holdi... (more story)

An Oregon federal judge agreed Wednesday to toss a proposed class action alleging a health company misspent forfeitures from two employee retirement plans by putting assets toward employer-side contribution ob... (more story)